We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

PERKIN ELMER CORPORATION

PerkinElmer provides detection technologies to detect and identify diseases, imaging technologies to help visualize s... read more Featured Products: More products

Download Mobile App





PerkinElmer Exhibits Automated Nucleic Acid Extraction Solutions at MEDLAB Middle East

By LabMedica International staff writers
Posted on 26 Jan 2022
Print article
Image: LabChip GX Touch Nucleic Acid Analyzer (Photo courtesy of PerkinElmer, Inc.)
Image: LabChip GX Touch Nucleic Acid Analyzer (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer, Inc. (Waltham, MA; USA) demonstrated its range of automated nucleic acid extraction solutions at the 2022 edition of MEDLAB Middle East held at the Dubai World Trade Centre (DWTC) from January 24 to 27.

PerkinElmer demonstrated its high-throughput Vanadis NIPT solution which takes all the complexity out of cell-free DNA (cfDNA) testing, making it accessible to more women – and more cost-effective for laboratories. This breakthrough technology eliminates PCR amplification and gene sequencing, making it so easy to use that one laboratory technician can handle 2000 to 20,000 samples per year. Walkaway automation streamlines the process from primary tube to final results. Because the Vanadis system is an easy to use, non-NGS and non-PCR based method, any laboratory can use it. Also on display was the LabChip GX Touch nucleic acid analyzer with microfluidic technology that allows DNA and RNA quantitation and sizing to be done in seconds using automated capillary electrophoresis separation.

In addition, PerkinElmer highlighted the chemagic Prepito instrument which is based on the company’s proven technology for magnetic bead based DNA/RNA isolation and represents a top quality sample preparation system available as a compact benchtop instrument. The innovative instrument realizes cost effectiveness through automated dispensing of buffers into standard plastic devices instead of using expensive pre-filled cartridges. It includes barcode reading to provide comfort and to support highest quality assurance demands. Hands-on time is minimized and the processing time is as short as 30 minutes for up to 12 samples per batch.

PerkinElmer also displayed the VICTOR Nivo multimode microplate reader, now with Alpha technology, which packs all popular detection modes into the industry’s smallest multimode reader footprint. The perfect microplate reader for everyday biochemical and cell-based assays, it measures at any wavelength, with top and bottom reading of all standard technologies (top only reading for Alpha). Among other instruments, PerkinElmer exhibited the DELFIA Xpress platform which has been developed to streamline workflows in laboratories and clinics providing prenatal screening services. The platform offers a variety of benefits critical for operational efficiency, and with a wide range of available kits it supports different strategies in aneuploidy and pre-eclampsia screening.

Related Links:
PerkinElmer, Inc. 

Gold Supplier
Lactate and Hemoglobin/Hematocrit Meter
StatStrip® LAC/Hb/Hct
New
Urine Analyzer
R-600S
New
Silver Supplier
Anti-Müllerian Hormone (AMH) ELISA Test
PCOCheck ELISA (CE)
New
Gold Supplier
Automatic Biochemistry Analyzer
Biossays C8

Print article

Channels

Clinical Chem.

view channel
Image: The analysis pipeline used to investigate associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease (Photo courtesy of University College London)

Lipid Measurements Show Potential as Alzheimer’s Disease Biomarkers

Brain changes accompanying ageing are varied and can include pathologies that lead to cognitive impairment, the commonest of which is Alzheimer’s disease (AD). Identifying blood-based signatures of brain... Read more

Molecular Diagnostics

view channel
Image: Guidance UTI provides personalized results in less than one day from receipt at lab (Photo courtesy of Pathnostics)

Rapid Result Test for Complicated Urinary Tract Infections Proves Superior to Standard Urine Culture

Complicated urinary tract infections (cUTIs) are a significant burden on individual health and healthcare resources that must be diagnosed and treated early and accurately to reduce the risk of poor outcomes.... Read more

Hematology

view channel
Image: The CS-2500 analyzer features pre-analytic sample checks and four detection methods simultaneously on a single platform – coagulation end-point, chromogenic kinetic analysis, turbidimetric immunoassay and automated platelet aggregation (Photo courtesy of Sysmex)

Microvascular/Endothelial Dysfunction Contributes to Post-COVID Syndrome Pathogenesis

Post-COVID syndrome (PCS) or Long-COVID is an increasingly recognized complication of acute SARS-CoV-2 infection, characterized by persistent fatigue, reduced exercise tolerance chest pain, shortness of... Read more

Industry

view channel
Image: Sales of lateral flow assays in clinical testing are expected to register a CAGR of 5% through 2032 (Photo courtesy of Pexels)

Global Lateral Flow Assays Market to Surpass USD 11.5 Billion by 2032 Due to Evolving Applications

The global lateral flow assays market was valued at USD 7.2 billion in 2021 and is projected to register a CAGR of 4.7% during 2022-2032 to surpass USD 11.7 billion by the end of 2032, driven by the growing... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.